Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Restless Legs Syndrome
Interventions
DRUG

Ropinirole Extended Release (XR)

Dose range of Ropinirole XR of 0.5mg to 6.0mg daily

Trial Locations (65)

10021

GSK Investigational Site, New York

12308

GSK Investigational Site, Schenectady

13760

GSK Investigational Site, Endwell

22311

GSK Investigational Site, Alexandria

22911

GSK Investigational Site, Charlottesville

27607

GSK Investigational Site, Raleigh

27834

GSK Investigational Site, Greenville

29201

GSK Investigational Site, Columbia

29464

GSK Investigational Site, Mt. Pleasant

30106

GSK Investigational Site, Austell

30189

GSK Investigational Site, Woodstock

30338

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

30534

GSK Investigational Site, Dawsonville

31201

GSK Investigational Site, Macon

33486

GSK Investigational Site, Boca Raton

33609

GSK Investigational Site, Tampa

33701

GSK Investigational Site, St. Petersburg

33773

GSK Investigational Site, Largo

34996

GSK Investigational Site, Stuart

35007

GSK Investigational Site, Alabaster

35501

GSK Investigational Site, Jasper

38305

GSK Investigational Site, Jackson

43232

GSK Investigational Site, Columbus

44130

GSK Investigational Site, Cleveland

48025

GSK Investigational Site, Bingham Farms

60523

GSK Investigational Site, Oak Brook

66214

GSK Investigational Site, Lenexa

66606

GSK Investigational Site, Topeka

70808

GSK Investigational Site, Baton Rouge

73112

GSK Investigational Site, Oklahoma City

75231

GSK Investigational Site, Dallas

78229

GSK Investigational Site, San Antonio

80033

GSK Investigational Site, Wheat Ridge

80212

GSK Investigational Site, Denver

80909

GSK Investigational Site, Colorado Springs

82653

GSK Investigational Site, Laguna Hills

84107

GSK Investigational Site, Salt Lake City

84121

GSK Investigational Site, Salt Lake City

85050

GSK Investigational Site, Phoenix

85201

GSK Investigational Site, Mesa

85351

GSK Investigational Site, Sun City

89119

GSK Investigational Site, Las Vegas

90277

GSK Investigational Site, Redondo Beach

90404

GSK Investigational Site, Santa Monica

91106

GSK Investigational Site, Pasadena

91325

GSK Investigational Site, Northridge

91355

GSK Investigational Site, Reseda

92103

GSK Investigational Site, San Diego

93030

GSK Investigational Site, Oxnard

97210

GSK Investigational Site, Portland

98405

GSK Investigational Site, Tacoma

98801

GSK Investigational Site, Wenatchee

99204

GSK Investigational Site, Spokane

99362

GSK Investigational Site, Walla Walla

01104

GSK Investigational Site, Springfield

08003

GSK Investigational Site, Cherry Hill

08755

GSK Investigational Site, Toms River

97504-8456

GSK Investigational Site, Medford

V3K 3P4

GSK Investigational Site, Coquitlam

V3A 4H9

GSK Investigational Site, Langley

L1S 2J5

GSK Investigational Site, Ajax

H2T 2N6

GSK Investigational Site, Montreal

J1H 1Z1

GSK Investigational Site, Sherbrooke

S4P 0W5

GSK Investigational Site, Regina

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY